Vir Biotechnology to Present at the 20th Annual Needham Virtual Healthcare Conference
06. April 2021 16:01 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, April 06, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that George Scangos, Ph.D., chief executive officer, will participate in a virtual fireside...
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2019 Financial Results
19. November 2019 16:15 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, Nov. 19, 2019 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies...